Long-Term Safety and Efficacy of Risankizumab Treatment in Patients With Crohn's Disease: 3-Year Interim Results From the Ongoing Phase 2 Open-Label Extension Study

被引：0
|
作者：
Ferrante, Marc [1 ]
Feagan, Brian G. [2 ]
Panes, Julian [3 ]
Baert, Filip [4 ]
Louis, Edouard [5 ,6 ]
Dewit, Olivier [7 ]
Kaser, Arthur [8 ]
Duan, Weijiang [9 ]
Gustafson, Dawn [9 ]
Liao, Xiaomei [9 ]
Wallace, Kori [9 ]
Kalabic, Jasmina [9 ]
D'Haens, Geert R. [10 ]
机构：
[1] Univ Hosp, Leuven, Oost Vlaanderen, Belgium
[2] Univ Western Ontario, London, ON, Canada
[3] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Catalonia, Spain
[4] AZ Delta Roeselare Menen, West Vlaanderen, Belgium
[5] CHU Liege, Liege, Belgium
[6] Univ Liege, Liege, Belgium
[7] Clin Univ St Luc, Brussels, Brussels Hoofds, Belgium
[8] Univ Cambridge, Cambridge, England
[9] AbbVie Inc, N Chicago, IL USA
[10] Acad Med Ctr, Amsterdam, Noord Holland, Netherlands
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000592760.20054.85
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
806
引用
收藏
页码：S466 / S466
页数：1
相关论文
共 50 条
  • [1] INTERIM LONG-TERM SAFETY/EFFICACY OF RISANKIZUMAB TREATMENT IN CROHN'S DISEASE PATIENTS FROM THE OPEN-LABEL EXTENSION STUDY
    Ferrante, M.
    Panes, J.
    Baert, F.
    Louis, E.
    Kaser, A.
    Gustafson, D.
    Hall, D.
    Boecher, W. O.
    Herichova, I.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G.
    [J]. GUT, 2019, 68 : A64 - A64
  • [2] Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, W. Rachel
    Pang, Yinuo
    Lee, Wan-Ju
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 (12): : 2001 - 2010
  • [3] LONG-TERM SAFETY AND EFFICACY OF RISANKIZUMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE: FINAL RESULTS FROM THE PHASE 2 OPEN-LABEL EXTENSION STUDY
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip J.
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, Weijiang
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1198 - S1198
  • [4] Long-term safety and efficacy of risankizumab treatment in patients with Crohn's disease: Final results from the Phase 2 open-label extension study
    Ferrante, M.
    Feagan, B. G.
    Panes, J.
    Baert, F.
    Louis, E.
    Dewit, O.
    Kaser, A.
    Duan, W. R.
    Gustafson, D.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G. R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S024 - S025
  • [5] Long-term Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease up to 3 Years of Treatment: Results From the FORTIFY Open-Label Long-term Extension
    Ferrante, M.
    Panaccione, R.
    Colombel, J. F.
    Dubinsky, M.
    Hisamatsu, T.
    Lindsay, J. O.
    Song, A.
    Neimark, E.
    Zhang, Y.
    Kligys, K.
    Crowley, J.
    Duan, W. R.
    D'Haens, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I167 - I169
  • [6] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
    Santos, Raul D.
    Duell, P. Barton
    East, Cara
    Guyton, John R.
    Moriarty, Patrick M.
    Chin, Wai
    Mittleman, Robert S.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (09) : 566 - 575
  • [8] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [9] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
  • [10] Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study
    Trauner, Michael
    Nevens, Frederik
    Shiffman, Mitchell L.
    Drenth, Joost P. H.
    Bowlus, Christopher L.
    Vargas, Victor
    Andreone, Pietro
    Hirschfield, Gideon M.
    Pencek, Richard
    Malecha, Elizabeth Smoot
    MacConell, Leigh
    Shapiro, David
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (06): : 445 - 453
12345